What is Frenalytics?
Frenalytics operates at the intersection of pedagogical science and data analytics, providing a robust software suite designed to automate progress monitoring and personalize learning pathways. The platform addresses critical pain points for educators and clinicians by streamlining the documentation of IEP goals and facilitating seamless communication between schools and families. By replacing manual, time-intensive reporting with automated, real-time insights, the company enables educators to focus on student outcomes rather than administrative overhead. Its market position is strengthened by its specific focus on underserved populations, including special education students and ELL learners, where the need for precise, individualized tracking is most acute.
How much funding has Frenalytics raised?
Frenalytics has raised a total of $300K across 1 funding round:
Other Financing Round
$300K
Other Financing Round (2022): $300K with participation from Forum Ventures
Key Investors in Frenalytics
Forum Ventures
Forum Ventures is a management consultancy and investment firm focused on accelerating the growth of early and mid-stage technology companies through data-derived strategy and tactical go-to-market execution.
What's next for Frenalytics?
With the recent influx of capital, Frenalytics is expected to prioritize the expansion of its product roadmap, focusing on advanced predictive analytics and enhanced integration capabilities with existing school district information systems. The strategic roadmap likely includes scaling its sales and marketing infrastructure to capture a larger share of the K-12 market, where demand for compliance-focused, user-friendly software remains high. As the company matures, it will likely leverage its proprietary data sets to refine its personalized learning algorithms, further cementing its role as an essential partner for districts aiming to improve student retention and academic performance through technology-enabled interventions.
See full Frenalytics company page